March 25, 2025 12:40 AM PDT
MARKET OVERVIEW:
The veterinary molecular diagnostics market is rapidly growing, driven by technological advancements and the increasing demand for faster, more accurate testing methods in veterinary care. The market reached a size of USD 745.6 million in 2024, and is projected to grow to USD 1,482.2 million by 2033, with a CAGR of 7.54%. Key drivers include rising pet ownership, the need for precise disease detection, and regulatory improvements in veterinary diagnostic standards.
STUDY ASSUMPTION YEARS:
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019-2024
- FORECAST YEAR: 2025-2033
VETERINARY MOLECULAR DIAGNOSTICS MARKET KEY TAKEAWAYS:
- The veterinary molecular diagnostics market is projected to reach USD 1,482.2 million by 2033, growing at a CAGR of 7.54%.
- Rising pet adoption and increased animal health expenditure are major growth factors.
- Demand for rapid, accurate disease detection technologies is driving innovations.
- North America leads the market due to high pet ownership and affordable diagnostic options.
- Personalized veterinary care is gaining traction, enhancing market outlook.
- Advancements in molecular diagnostic tools, like Real-Time PCR, Microarrays, and DNA Sequencing, continue to improve diagnostic accuracy.
MARKET GROWTH FACTORS:
Increasing Pet Ownership:
In developed areas, the commonophilia creates demand for veterinary services, including diagnostics. As pets are increasingly considered part of the family, pet owners demand ever-more-modern veterinary diagnostic tools for their pets' well-being. This cultural phenomenon and the growth of the global pet population directly escalate the growth of the veterinary molecular diagnostics market. Consequently, demand for accurate and quick diagnostic tools soared, especially in areas with widespread pet ownership, especially in North America and Europe.
Technological Advancements in Molecular Diagnostics:
However, the developments on this market are supported by advancements in molecular diagnostic technologies-like Real-Time PCR, DNA Sequencing, and Microarrays-which allow for accurate, rapid, and non-invasive disease detection in animals. The veterinary profession has really changed in terms of these technologies. With the use of these technologies, veterinarians are able to make more accurate diagnoses of infections and genetic disorders, consequently improving treatment outcomes. This development, along with point-of-care diagnostics, enhances this market scenario by allowing swift decisions to be made by veterinarians about animal health management.
Rising Prevalence of Animal Diseases:
With the rise of animal diseases comes an increase in demand for advanced diagnostic solutions. Zoonoses around the world and the effects of animal health problems on economies, as seen with bovine respiratory diseases or parasitic infections, make strong cases for facing this need for accurate diagnostics. Molecular diagnostics will help with early disease detection and break the vicious cycle of infections with their subsequent economic loss to agriculture and the livestock industry. This augmented need for effective and reliable diagnostic tools serves as the banner carrier for this market, especially in very intensive animal husbandry settings and in disease-burdened countries.
MARKET SEGMENTATION:
- By Product:
- Kits and Reagents: Essential components for diagnostic testing, providing necessary materials for molecular analysis.
- Instruments: Devices used for performing diagnostic tests, such as PCR machines.
- Software and Services: Support tools for managing data and ensuring diagnostic accuracy.
- By Technology:
- Real-Time PCR: A widely used method for detecting and quantifying DNA or RNA in pathogens.
- Microarray: Technology used to analyze gene expression and detect multiple pathogens simultaneously.
- DNA Sequencing: A method for determining the exact sequence of nucleotides in animal DNA.
- By Animal Type:
- Companion Animals: Dogs, cats, and other pets commonly requiring veterinary diagnostics.
- Livestock Animals: Animals like cattle, poultry, and pigs that are crucial in agricultural economies.
- By Disease Type:
- Vector-borne Diseases: Diseases transmitted by vectors like ticks or mosquitoes.
- Respiratory Pathogens: Pathogens affecting the respiratory system, such as pneumonia.
- Diarrhea Pathogens: Pathogens causing gastrointestinal infections in animals.
- Others: Other diseases requiring molecular diagnostic tests.
- By End-User:
- Veterinary Hospitals: Institutions providing comprehensive care, including diagnostic testing.
- Clinical Laboratories: Labs specializing in animal diagnostics.
- Research Institutes: Organizations conducting research on veterinary diseases and diagnostics.
- Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
REGIONAL INSIGHTS:
There has been an increase in the importance of North America as the dominant region for the veterinary molecular diagnostics market due to the high occupancy of pets by their owners and the good accessibility of veterinary care. Pet humanization trends and corresponding advances in technologies, in particular supporting the demand for precise diagnostic solutions within the region. Furthermore, North American regulation provides additional impetus towards innovation and adoption of these diagnostic tools into veterinary practice.
RECENT DEVELOPMENTS & NEWS:
Innovations are indeed apparent in veterinary molecular diagnostics markets nowadays, including development of point-of-care diagnostic tools. Companies are directed toward improving speed and accuracy of molecular tests for a range of diseases for pet animals and farm animals. The advances are enhancing the efficiency of veterinary healthcare and driving realization of demand for individualized medicine in animal health.
KEY PLAYERS:
- Biochek B.V.
- bioMérieux SA
- HealthGene Corporation
- Heska Corporation
- IDEXX Laboratories Inc.
- INDICAL BIOSCIENCE GmbH
- Ingenetix GmbH
- NEOGEN Corporation
- Qiagen N.V
- Thermo Fisher Scientific Inc.
- Veterinary Molecular Diagnostics Inc.
- Zoetis Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, considerations studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
MARKET OVERVIEW:
The veterinary molecular diagnostics market is rapidly growing, driven by technological advancements and the increasing demand for faster, more accurate testing methods in veterinary care. The market reached a size of USD 745.6 million in 2024, and is projected to grow to USD 1,482.2 million by 2033, with a CAGR of 7.54%. Key drivers include rising pet ownership, the need for precise disease detection, and regulatory improvements in veterinary diagnostic standards.
STUDY ASSUMPTION YEARS:
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019-2024
- FORECAST YEAR: 2025-2033
VETERINARY MOLECULAR DIAGNOSTICS MARKET KEY TAKEAWAYS:
- The veterinary molecular diagnostics market is projected to reach USD 1,482.2 million by 2033, growing at a CAGR of 7.54%.
- Rising pet adoption and increased animal health expenditure are major growth factors.
- Demand for rapid, accurate disease detection technologies is driving innovations.
- North America leads the market due to high pet ownership and affordable diagnostic options.
- Personalized veterinary care is gaining traction, enhancing market outlook.
- Advancements in molecular diagnostic tools, like Real-Time PCR, Microarrays, and DNA Sequencing, continue to improve diagnostic accuracy.
MARKET GROWTH FACTORS:
Increasing Pet Ownership:
In developed areas, the commonophilia creates demand for veterinary services, including diagnostics. As pets are increasingly considered part of the family, pet owners demand ever-more-modern veterinary diagnostic tools for their pets' well-being. This cultural phenomenon and the growth of the global pet population directly escalate the growth of the veterinary molecular diagnostics market. Consequently, demand for accurate and quick diagnostic tools soared, especially in areas with widespread pet ownership, especially in North America and Europe.
Technological Advancements in Molecular Diagnostics:
However, the developments on this market are supported by advancements in molecular diagnostic technologies-like Real-Time PCR, DNA Sequencing, and Microarrays-which allow for accurate, rapid, and non-invasive disease detection in animals. The veterinary profession has really changed in terms of these technologies. With the use of these technologies, veterinarians are able to make more accurate diagnoses of infections and genetic disorders, consequently improving treatment outcomes. This development, along with point-of-care diagnostics, enhances this market scenario by allowing swift decisions to be made by veterinarians about animal health management.
Rising Prevalence of Animal Diseases:
With the rise of animal diseases comes an increase in demand for advanced diagnostic solutions. Zoonoses around the world and the effects of animal health problems on economies, as seen with bovine respiratory diseases or parasitic infections, make strong cases for facing this need for accurate diagnostics. Molecular diagnostics will help with early disease detection and break the vicious cycle of infections with their subsequent economic loss to agriculture and the livestock industry. This augmented need for effective and reliable diagnostic tools serves as the banner carrier for this market, especially in very intensive animal husbandry settings and in disease-burdened countries.
MARKET SEGMENTATION:
- By Product:
- Kits and Reagents: Essential components for diagnostic testing, providing necessary materials for molecular analysis.
- Instruments: Devices used for performing diagnostic tests, such as PCR machines.
- Software and Services: Support tools for managing data and ensuring diagnostic accuracy.
- By Technology:
- Real-Time PCR: A widely used method for detecting and quantifying DNA or RNA in pathogens.
- Microarray: Technology used to analyze gene expression and detect multiple pathogens simultaneously.
- DNA Sequencing: A method for determining the exact sequence of nucleotides in animal DNA.
- By Animal Type:
- Companion Animals: Dogs, cats, and other pets commonly requiring veterinary diagnostics.
- Livestock Animals: Animals like cattle, poultry, and pigs that are crucial in agricultural economies.
- By Disease Type:
- Vector-borne Diseases: Diseases transmitted by vectors like ticks or mosquitoes.
- Respiratory Pathogens: Pathogens affecting the respiratory system, such as pneumonia.
- Diarrhea Pathogens: Pathogens causing gastrointestinal infections in animals.
- Others: Other diseases requiring molecular diagnostic tests.
- By End-User:
- Veterinary Hospitals: Institutions providing comprehensive care, including diagnostic testing.
- Clinical Laboratories: Labs specializing in animal diagnostics.
- Research Institutes: Organizations conducting research on veterinary diseases and diagnostics.
- Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
REGIONAL INSIGHTS:
There has been an increase in the importance of North America as the dominant region for the veterinary molecular diagnostics market due to the high occupancy of pets by their owners and the good accessibility of veterinary care. Pet humanization trends and corresponding advances in technologies, in particular supporting the demand for precise diagnostic solutions within the region. Furthermore, North American regulation provides additional impetus towards innovation and adoption of these diagnostic tools into veterinary practice.
RECENT DEVELOPMENTS & NEWS:
Innovations are indeed apparent in veterinary molecular diagnostics markets nowadays, including development of point-of-care diagnostic tools. Companies are directed toward improving speed and accuracy of molecular tests for a range of diseases for pet animals and farm animals. The advances are enhancing the efficiency of veterinary healthcare and driving realization of demand for individualized medicine in animal health.
KEY PLAYERS:
- Biochek B.V.
- bioMérieux SA
- HealthGene Corporation
- Heska Corporation
- IDEXX Laboratories Inc.
- INDICAL BIOSCIENCE GmbH
- Ingenetix GmbH
- NEOGEN Corporation
- Qiagen N.V
- Thermo Fisher Scientific Inc.
- Veterinary Molecular Diagnostics Inc.
- Zoetis Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, considerations studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.